Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

My point is this, if Tempus AI's management themselves struggle to have enough visibility into its growth rates, what hope do outside, passive investors have? Given this background, let's now ...

Tempus Ai got a big valuation boost following a disclosure that Nancy Pelosi had purchased call options for the stock. The healthcare AI company also unveiled its new software service today.

Multiple executives at Tempus AI Inc. TEM executed significant share sales totaling $20.3 million between Feb. 4-7, according to recent Securities and Exchange Commission filings. The transactions ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing.

Ryan M. Bartolucci, Chief Accounting Officer at Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of company stock, according to a recent SEC filing. On February 5, Bartolucci ...